© 1997 American Heart Association, Inc.
Articles |
Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery
From the Department of Applied Pharmacology (D.B.-B., S.W.L.) and Department of Thoracic Medicine (E.-B.H., R.N.), National Heart and Lung Institute, Imperial College of Science, Technology and Medicine; and Department of Cardiothoracic Surgery (J.R.P.) and Department of Anaesthetics and Critical Care Medicine (J.A.M.), Royal Brompton National Heart and Lung Hospital, London, UK.
Correspondence to Dr Jane A. Mitchell, Department of Anaesthetics and Critical Care Medicine, Royal Brompton National Heart and Lung Hospital, Sydney Street, London SW3 6NP, UK.
Abstract Within vessels, cyclooxygenase
(COX) is expressed constitutively (COX-1) in
endothelial cells where its production of
prostacyclin is thought to contribute to the maintenance of
vascular integrity. Recently, a novel isoform of COX, COX-2, has been
described that is induced in animal arterial vessels after
physical damage or exposure to proinflammatory cytokines.
However, induction of COX-2 in human vessels has not been
characterized. Moreover, the relative ability of arteries and veins to
express COX-2 has not been addressed. Thus, we have compared the
ability of segments of human saphenous vein and internal mammary
artery, obtained from the same patient, to express COX-2 activity and
mRNA after organ culture in the presence and absence of
interleukin-1ß. COX-2 metabolites, measured by radioimmunoassay, were
released by both the internal mammary artery and saphenous vein in the
following rank order: prostaglandin
E2
prostacyclin thromboxane
A2. Inclusion of interleukin-1ß in the culture medium
increased the release of prostanoids by the saphenous vein but not by
the internal mammary artery. However, the selective COX-2
inhibitor NS-398 significantly attenuated prostacyclin
release from both tissues. Northern blot analysis showed no
detectable COX-2 mRNA in freshly prepared saphenous vein or internal
mammary artery. In contrast, after 48 hours in organ culture, low
levels of COX-2 mRNA were detected in both internal mammary artery and
saphenous vein, an effect that was greatly increased by
interleukin-1ß. These observations show that COX-2 is induced in
human saphenous vein and internal mammary artery and suggest that this
may occur in humans after coronary artery bypass graft surgery.
The induction of COX-2 and subsequent release of prostacyclin may
represent an endogenous defense mechanism against
endothelial damage incurred during surgical preparation
of these vessels for bypass.
Key Words: cyclooxygenase • saphenous vein • internal mammary artery • prostacyclin
This article has been cited by other articles:
 |
|
 |
|
  N. Foudi, L. Louedec, T. Cachina, C. Brink, and X. Norel Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation Cardiovasc Res, February 1, 2009; 81(2): 269 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Harrington, R. Lucas, S. K. McMaster, L. Moreno, G. Scadding, T. D. Warner, and J. A. Mitchell COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma FASEB J, November 1, 2008; 22(11): 4005 - 4010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-T. Hong, J. Huang, T. D. Barrett, and B. R. Lucchesi Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H145 - H155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bishop-Bailey, J. A. Mitchell, and T. D. Warner COX-2 in cardiovascular disease. Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 956 - 958. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fosslien Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 347 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takayama, G. Garcia-Cardena, G. K. Sukhova, J. Comander, M. A. Gimbrone Jr., and P. Libby Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor J. Biol. Chem., November 8, 2002; 277(46): 44147 - 44154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bishop-Bailey, T. Hla, and T. D. Warner Intimal Smooth Muscle Cells as a Target for Peroxisome Proliferator-Activated Receptor-{gamma} Ligand Therapy Circ. Res., August 9, 2002; 91(3): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Caughey, L. G. Cleland, P. S. Penglis, J. R. Gamble, and M. J. James Roles of Cyclooxygenase (COX)-1 and COX-2 in Prostanoid Production by Human Endothelial Cells: Selective Up-Regulation of Prostacyclin Synthesis by COX-2 J. Immunol., September 1, 2001; 167(5): 2831 - 2838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lazzeri, M. G. Belvisi, H. J. Patel, M. H. Yacoub, K. Fan Chung, and J. A. Mitchell Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells . Relevance to Asthma Therapy Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 44 - 48. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Stanford, J. R. Pepper, and J. A. Mitchell Cyclooxygenase-2 Regulates Granulocyte-Macrophage Colony-Stimulating Factor, but Not Interleukin-8, Production by Human Vascular Cells : Role of cAMP Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 677 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto Increase in Prostaglandin E2 Production by Interleukin-1{beta} in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease Circ. Res., November 12, 1999; 85(10): 912 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schonbeck, G. K. Sukhova, P. Graber, S. Coulter, and P. Libby Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions Am. J. Pathol., October 1, 1999; 155(4): 1281 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Woods, J. A. Mitchell, E. G. Wood, S. Barker, N. R. Walcot, G. M. Rees, and T. D. Warner Endothelin-1 Is Induced by Cytokines in Human Vascular Smooth Muscle Cells: Evidence for Intracellular Endothelin-Converting Enzyme Mol. Pharmacol., May 1, 1999; 55(5): 902 - 909. [Abstract] [Full Text]
|
|
|
|
|
|
T. G. Brock, R. W. McNish, and M. Peters-Golden Arachidonic Acid Is Preferentially Metabolized by Cyclooxygenase-2 to Prostacyclin and Prostaglandin E2 J. Biol. Chem., April 23, 1999; 274(17): 11660 - 11666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Beasley COX-2 and cytosolic PLA2 mediate IL-1beta -induced cAMP production in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1369 - H1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bishop-Bailey, J. R. Pepper, S. W. Larkin, and J. A. Mitchell Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth Muscle : Role of Endogenous Prostanoids Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1655 - 1661. [Abstract] [Full Text] [PDF]
|
|